Silicon and titanium oxide surfaces (SiO2/Si and TiO2/Ti) were covalently m
odified with bioactive molecules (e.g., peptides) in a simple three-step pr
ocedure. Bioactive surfaces were synthesized by first immobilizing N-(2-ami
noethyl)-3-aminopropyl-trimethoxysilane (EDS) to either polished quartz dis
ks, polished silicon wafers, or sputter-deposited titanium films. Subsequen
tly, a maleimide-activated surface amenable to tethering molecules with a f
ree thiol (e.g., cysteine) was created by coupling sulfosuccinimidyl 4-(N-m
aleimidomethyl) cyclohexane-1-carboxylate (sulfo-SMCC) to the terminal amin
e on EDS. In particular, Cys-Gly-Gly-Asn-Gly-Glu-Pro-Arg-Gly-Asp-Thr-Tyr-Ar
g-Ala-Tyr (-RGD-) and Cys-Gly-Gly-Phe-His-Arg-Arg-Ile-Lys-Ala (-FHRRIKA-) p
eptides with terminal cysteine residues were immobilized on maleimide-activ
ated oxides. X-ray photoelectron spectroscopy (XPS) and spectroscopic ellip
sometry were used to assess the chemistry, thickness, and surface density o
f the grafted layers. EDS deposited from anhydrous methanol produced reacti
on site-limited monolayers (similar to 0.28 nmol/cm(2)). Coupling of the su
lfo-SMCC crosslinker (similar to 0.03 nmol/cm(2)) and peptides (similar to
0.004 nmol/cm(2)) resulted in an order of magnitude drop in surface density
for each stage of the reaction scheme. Peptide-modified surfaces with dens
ities varying over 2 orders (0.01-4 pmol/cm(2)) of magnitude were synthesiz
ed to study the effect of the peptides on mammalian cell function. The adhe
sion and spreading of cells derived from mammalian bone, in contact with th
e peptide-modified surfaces, was dependent on the specific peptide sequence
grafted in a concentration-dependent manner. The grafting scheme presented
has generality in coupling thiol-specific molecules to silicon or titanium
surfaces.